STAR/StarD1, part of a protein complex, mediates the transport of cholesterol from the outer to inner mitochondrial membrane, which is the rate-limiting step for steroidogenesis, and where steroid hormone synthesis begins. Herein, we examined the role of oxidant-sensitive p38 MAPKs in the regulation of STAR gene transcription, using model steroidogenic cell lines. Our data indicate that oxidant activation of p38 MAPK exhibits a negative regulatory role in the induction of functional expression of STAR, as evidenced by enhanced induction of STAR (mRNA/protein) expression and increased steroidogenesis during pharmacological inhibition of p38 MAPK or in cells with increased transient overexpression of a dominantnegative (dn) form of p38 MAPKa or p38 MAPKb. Studies with rat Star-promoter demonstrated that overexpression of p38 MAPKa-wt, -b, or -g significantly reduced both basal and cAMP-sensitive promoter activity. In contrast, overexpression of p38 MAPKa-dn, -b, or -g enhanced the Star promoter activity under basal conditions and in response to cAMP stimulation. Use of various constitutively active and dn constructs and designer knock-out cell lines demonstrated that MKK3 and MKK6, the upstream activators of p38 MAPKs, play a role in p38 MAPKa-mediated inhibition of Star promoter activity. In addition, our studies raised the possibility of CREB being a potential target of the p38 MAPK inhibitory effect on Star promoter activity. Collectively, these data provide novel mechanistic information about how oxidant-sensitive p38 MAPKs, particularly p38 MAPKa, contribute to the negative regulation of Star gene expression and inhibit steroidogenesis.
Introduction
Extensive experimental evidence now indicates that aging in humans and animal models is associated with a general decline in steroid hormone production (Zaidi et al. 2012) . Similarly, a number of in vitro studies have clearly shown that isolated adrenocortical cells and testicular Leydig cells (Zaidi et al. 2012 ) of older rats of several different strains synthesize and secrete less steroid hormone in response to tropic hormone or its second messenger, cAMP, than do cells from younger animals. These changes in steroid hormone production and secretion do not appear to be a function of reduced tropic hormone signaling or a defect in steroid hormone-synthesizing enzymes.
Previous work from this laboratory has shown that an adequate amount of cholesterol is not available to the adrenal (adrenocortical cells) and testis (Leydig cells) in aging rats (Popplewell & Azhar 1987 , Liao et al. 1993 , Sun et al. 2008 , Zaidi et al. 2012 for the initial and rate-limiting step in steroid biosynthesis, i.e. translocation of cholesterol from the outer mitochondrial membrane (OMM) to the P450 side-chain cleavage enzyme (P450scc/Cyp11A1), which is localized in the matrix side of the inner mitochondrial membrane (IMM) and converts cholesterol to pregnenolone, the precursor of all steroid hormones (Stocco & Clark 1996 , Stocco 2001 , Hu et al. 2010 , Miller & Bose 2011 ). This aging-induced attenuation of cholesterol transport to mitochondria is not due to a loss of cellular cholesterol stores, but results from the downregulation of STAR (Leers-Sucheta et al. 1999 , Luo et al. 2001 , Wang et al. 2005 , Sun et al. 2008 ) and peripheral-type benzodiazepine receptor or translocator protein (TSPO; Culty et al. 2002 , Sun et al. 2008 . These components of the steroidogenic machinery (Stocco & Clark 1996 , Stocco 2001 probably function in concert (Liu et al. 2006) to facilitate ratelimiting cholesterol transport from the OMM to the IMM (Hu et al. 2010 , Miller & Bose 2011 . Although various cellular and molecular mechanisms controlling this aging defect have not been definitely identified, excessive reactive oxygen species (ROS) production , Cao et al. 2004 , Abidi et al. 2008a ,b, Zaidi et al. 2012 and ROS-induced oxidative damage to STAR have been suggested as a potential mechanism for impaired cholesterol transport to the IMM for steroid production during aging.
p38 MAPKs are members of the MAPK family that are activated by a variety of environmental stresses and inflammatory cytokines (Roux & Blenis 2004 , Coulthard et al. 2009 , Cuadrado & Nebreda 2010 , Remy et al. 2010 , Corrêa & Eales 2012 . The four members of the p38 MAPK isoform family are p38 MAPKa (MAPK14), p38 MAPKb (SAPK2b), p38 MAPKg (SAPK3, ERK6, or MAPK14), and p38 MAPKd (SAPK4 or MAPK13) (Han et al. 1994 , Lee et al. 1994 , Rouse et al. 1994 , Coulthard et al. 2009 , Cuadrado & Nebreda 2010 , Remy et al. 2010 . These isoforms differ in their organ/tissue distribution, regulation of kinase activation and subsequent phosphorylation of downstream substrates, kinases or transcription factors, and sensitivity to pharmacological inhibition by pyridinyl imidazole molecules such as SB203580 and SB202190 (Bain et al. 2007 , Coulthard et al. 2009 , Cuadrado & Nebreda 2010 , Remy et al. 2010 . Various forms of cellular stress, including oxidative stress, u.v. irradiation, hypoxia, and ischemia, as well as inflammatory cytokines, stimulate the activity of p38 MAPKs (Coulthard et al. 2009 , Cuadrado & Nebreda 2010 , Remy et al. 2010 by dual phosphorylation of Thr 180 and Tyr 182 in a Thr-Gly-Tyr motif. This phosphorylation is mediated by upstream MAPKs (MAPKKs), MKK3 and MKK6 (Derijard et al. 1995 , Raingeaud et al. 1995 , Han et al. 1996 , which are in turn activated by several different and overlapping sets of MAPKKKs or MEKKs (Coulthard et al. 2009 , Cuadrado & Nebreda 2010 , Remy et al. 2010 . Recently, we have shown that aging leads to increased activation of p38 MAPKa in rat adrenocortical cells (Abidi et al. 2008a) . This effect appears to be specific for p38 MAPKa, as the expression of neither ERK1/2 nor JNK1/2 was altered during aging (Abidi et al. 2008a) . We also showed that the use of p38 MAPK inhibitors (SB203580 and SB202190) and antioxidants (NAC and MnTMPyP) partially restored the steroidogenesis in adrenal cells from old animals, indicating that the p38 MAPK signaling cascade facilitates the inhibitory actions of excessive oxidative insult on adrenal steroid hormone production caused by aging (Abidi et al. 2008a) . These results were further complemented by in vitro studies using a mouse adrenocortical tumor cell line, Y-1, showing that activated p38 MAPKs mediate oxidant (excessive oxidative stress)-induced inhibition of steroid production (Abidi et al. 2008b) .
In the present study, we sought to determine molecular mechanisms by which the oxidant-sensitive p38 MAPK inhibits cAMP-induced steroidogenesis. Herein, we show that the inhibitory effect of p38 MAPK on cAMP-induced steroidogenesis in model steroidogenic cell lines is due to a decrease in StAR expression and its promoter activity. Furthermore, expression and functional activity of cAMP response-element binding protein (CREB), a mediator of tropic hormone/cAMPstimulated STAR gene transcription, is also sensitive to the inhibitory actions of p38 MAPK. The current study describes the molecular events responsible for the p38 MAPK-mediated negative regulation of STAR gene transcription and inhibition of steroidogenesis.
Materials and methods
Reagents and antibodies 
Plasmids
The generation of Rat Star promoter-pGL3 constructs p-1862-luc, p-1413-luc, p-998-luc, p-545-luc, and p-342-luc has been described in an earlier publication (Sandhoff et al. 1998) . The mouse Star promoter constructs, pGL3 (p-966-luc; Manna et al. 2002) , were kindly supplied by Dr Douglas Stocco (Texas Tech University Health Sciences Center, Lubbock, TX, USA). The pcDNA3-Flag-tagged-p38 MAPKa-wt, p38 MAPKb-wt, p38 MAPKg-wt, p38 MAPKdwt, p38 MAPKa/AF-dn (dominant negative) p38 MAPKb/AF-dn, p38 MAPKg/AF-dn, and p38 MAPKd/AF-dn constructs used here have been described previously (Pramanik et al. 2003 
Cell culture
Mouse Y-1 adrenocortical tumor cells, mouse MLTC-1 testicular Leydig tumor cells, and human embryonic kidney-293 (HEK-293) cells were originally obtained from the American Type Culture Collection (ATCC) (Manassas, VA, USA). MLTC-1 cells were maintained in RPMI 1640 medium with 10% fetal bovine serum (FBS), 100 mg/ml streptomycin, 100 units/ml penicillin, and 1%
L-glutamine in a humidified atmosphere of 5% CO 2 at 37 8C. Y-1 cells were maintained at 37 8C in a humidified 5% CO 2 atmosphere in Ham's F-10 medium supplemented with 2.5% FBS, 12.5% horse serum, 100 mg/ml streptomycin, and 100 units/ml penicillin. MKK3/6 wt, MKK3 K/K , MKK6 K/K , and MKK3/6 double knock-out (DKO) mouse embryonic fibroblasts (MEFs) (Brancho et al. 2003) were maintained in DMEM containing 10% FBS, 100 mg/ml streptomycin, and 100 units/ml penicillin at 37 8C with 5% CO 2 .
Transfections and luciferase assays MLTC-1 (or other cell types such as Y1, and MEFs, MKK3/6 wt, MKK3 described earlier. After overnight incubation, cells were transiently transfected with a rat p-1862 Star-Luc (firefly luciferase) construct (1 mg)Gnative p38 MAPKa (wt) (1 mg) or dn p38 MAPKa (1 mg) using Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen, Life Technologies). A control reporter construct containing Renilla luciferase (Rluc, pRL-TK) (50 ng) was co-transfected for normalization of transfection efficiency. In some cases, MLTC-1 cells were transfected with rat p-1862 Star-Luc (firefly luciferase) construct (1 mg)CpRL-TK (50 ng) and G p38 MAPKb-wt (1 mg), G p38 MAPKbdn, G p38 MAPKg-wt (1 mg), G p38 MAPKg-dn (1 mg),
In each case, total DNA concentration was kept constant to 3 mg with the addition of inert pcDNA3. After 48 h, cells were incubated with or without Bt 2 cAMP for 5 h, washed, harvested using cell lysis buffer (Promega Corporation), and subsequently assayed for both firefly and Renilla luciferase activities using the Promega Dual-Luciferase Reporter Kit (E1980) and a SpectraMax L luminescence Microplate Reader (Molecular Devices, Sunnyvale, CA, USA) or GloMax-20/20 Single-Tube Luminometer (Promega Corporation). Firefly luciferase activities were normalized to Renilla luciferase reporter activities and shown as -fold induction compared with control (empty vector). The results shown are the average of triplicate determinations with the error bars representing S.E.M. All the experiments were independently repeated at least two to three times.
In other assays, MLTC-1 cells were transfected with CRE-luc (firefly luciferase)CRenilla luciferase (Rluc, pRL-TK), G CREB, or G CREBCp38 MAPKa-wt or p38 MAPKa-dn, for 48 h. At the end of incubation, washed dishes were further incubated with or without Bt 2 cAMP followed by measurement of firefly and Renilla luciferase activities. Likewise, MLTC-1 cells were transfected with AP1/TRE-luc (firefly luciferase)CRenilla luciferase (Rluc, pRL-TK) G p38 MAPKawt or p38 MAPKa-dn and, after 48 h, dishes were further incubated with or without AP1/TRE activator TPA (10 nM) for 30 min. The cell lysates were then quantified for firefly and Renilla luciferase activities.
Transfection of MLTC-1 cells with p38 MAPK constructs and measurement of steroid (progesterone) secretion MLTC-1 cells were seeded at a density of 1!10 5 cells/well in a 12-well plate containing RPMI 1640 medium supplemented with 10% FBS, 100 mg/ml streptomycin, 100 units/ml penicillin, and 1% L-glutamine (under 5% CO 2 at 37 8C) for 24 h before transfection. The cells were transfected with native wt-p38 MAPKa (1 mg) and/or dn-p38 MAPKa (1 mg) or pcDNA3 (3 mg) using Lipofectamine 2000 as recommended by the manufacturer (Invitrogen, Life Technologies). In each case, the total amount of plasmid (3 mg) was kept the same with the addition of inert pcDNA3. Forty-eight hours after transfection, the medium was replaced with a fresh medium and the cells (triplicate wells) were treated with G Bt 2 cAMP (2.5 mM) and incubations continued for an additional 5 h. At the end of incubation, media were aspirated and stored frozen until analyzed for secreted progesterone content by RIA as described earlier . The cells were washed once with PBS and then processed for the determination of Star/StarD1 mRNA expression by quantitative RT-PCR as described below.
Quantitative real-time PCR
Total RNA from MLTC-1 and Y-1 cells was isolated by using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. RNA concentration and purity were quantified using a NanoDrop Spectrophotometer (Thermo Scientific). Samples (2 mg) RNA were reverse transcribed to cDNA at 42 8C for 1 h using SuperScript II reverse transcriptase (Invitrogen) and oligo(dT) and random hexamers. Quantitative real-time PCR (qRT-PCR) was carried out using specific primers (Table 1 ) and amplified using SYBR Select Master Mix for CFX (Applied Biosystems) in an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). The results are presented as relative mRNA expression levels calculated using the formula 2 KDDCT , where DDCTZDCT target KDCT reference with 36B4 (60S acidic ribosomal protein P0) as the reference gene.
Western blotting analysis
The cells were washed with PBS and then harvested in RIPA buffer, containing a Complete Protease Inhibitor Cocktail and PhosSTOP phosphatase inhibitor cocktail (both from Roche Diagnostics) directly to plates and scraping into tubes. The cells were briefly sonicated, and centrifuged for 5 min. The protein concentrations of the lysates were measured using the Pierce BCA Protein Assay Reagent Kit (Thermo Fischer Scientific, Rockford, IL, USA). Proteins from cell lysates (20 mg) were resolved on a precast 4-20% gradient SDS-PAGE and electro-transferred onto a Hybond nitrocellulose membrane (Amersham, GE Healthcare, Piscataway, NJ, USA). The membranes were blocked, incubated with anti-p38 MAPK, anti-phosphop38 MAPK, anti-CREB, anti-phospho-CREB, and mouse anti-b-actin antibodies, washed, and incubated with IRDye 800CW goat anti-rabbit and IRDye 680LT goat anti-mouse secondary antibodies. The membrane blots were then imaged using an ODYSSEY Infrared Imaging System (LI-COR Biosciences). Quantification of bands was made with the analysis software provided with the imaging system.
Statistical analysis
Data are presented as meanGS.E.M. Statistical analyses were performed using ANOVA followed by the Bonferroni's post test using GraphPad Prism Software, Prism 4 (GraphPad Software, Inc., San Diego, CA, USA). A P value of !0.05 was considered statistically significant. All experiments were performed independently at least three times.
Results
Effect of Bt 2 cAMP stimulation on mRNA levels of Star and Star-related lipid transfer proteins in MLTC-1 and Y-1 cells
The human and mouse genomes each contain 15 genes encoding Star-related lipid transfer (START) domaincontaining proteins (STARD; Soccio & Breslow 2003) . STAR (STARD1), the prototype of the STARD family of proteins, plays an essential role in moving cholesterol substrate to the IMM of steroidogenic cells of the adrenal gland and gonads, where the first committed step in steroidogenesis occurs (Stocco 2001 , Miller & Bose 2011 ).
Herein, we assessed the mRNA levels of Star (StarD1) (subsequently referred to as Star) and other StarD family members under basal conditions and in response to cAMP stimulation in two steroidogenic cell lines, MLTC-1 and Y-1. Total RNA samples were analyzed for Star, StarD2, 3, 4, 5, 6, 7, and 10 mRNA expression by qRT-PCR. The results shown in Fig. 1 indicate that Star mRNA is most abundantly expressed in both MLTC-1 and Y-1 cells and that Bt 2 cAMP (a cell-permeable analog of cAMP) stimulation further increased its mRNA levels by four-to fivefold in both cell types. Relatively low mRNA expression of StarD4 and StarD7 was also detected in MLTC-1 cells, and Bt 2 cAMP (2.5 mM) treatment of these cells enhanced StarD4 expression by four-to fivefold (Fig. 1) . In Y-1 cells, low, but significant, mRNA expression was noted for StarD4, StarD5, and StarD7, although their levels were not affected by Bt 2 cAMP stimulation. The higher levels of mRNA expression of STAR protein compared with other STARD proteins in MLTC-1 and Y-1 cells are consistent with its critical role in the regulation of steroidogenesis.
Expression of endogenous mRNA levels of p38 MAPK isoforms in MLTC-1 and Y-1 cells
Using qRT-PCR, we next determined the relative mRNA expression levels of each of the four p38 MAPK isoforms in MLTC-1 and Y-1 cells (Fig. 2 ). p38 MAPKa expression was most abundant in both cell types; only low levels of p38 MAPKb were detected in Y-1 cells, while its mRNA levels were roughly 40% of the levels of p38 MAPKa in MLTC-1 cells (Fig. 2) . Low levels of p38 MAPKg mRNA were also detected in Y-1 cells as well as in MLTC-1 cells. The expression of p38 MAPKd, however, was barely detectable in MLTC-1, and Y-1 cells showed only low expression 
Journal of Molecular Endocrinology
Research S K ZAIDI and others p38 MAPK inhibition of STAR gene transcription 53:1 (Fig. 2) . These results led us to conclude that p38 MAPKa is the predominant form in both cell types, but significant expression of p38 MAPKb and p38 MAPKg was also detected in MLTC-1 and Y-1 cells respectively. Thus, most of the follow-up studies focused on the p38 MAPKa isoform.
Effects of oxidants and Bt 2 cAMP on Star mRNA expression in steroidogenic cell lines
To examine the effect of oxidants on Star mRNA expression, MLTC-1 and Y-1 cells were pre-exposed to xanthine/XO (X/XO; superoxide anion), hydrogen peroxide, lipid peroxidation product, HNE, or vehicle (control) for 1 h, the dishes washed and treated or not treated a cell membrane-permeable cAMP analog, Bt 2-cAMP, for 5 h. Total RNA was isolated and Star mRNA measured using qRT-PCR. When cells were treated for 5 h, the results demonstrated that Star mRNA levels, as expected, increased threefold to fourfold following treatment with 2.5 mM Bt 2 cAMP compared with nontreatment control (Fig. 3) . Treatment of cells with a superoxidegenerating system (X/XO), hydrogen peroxide, or a lipid peroxidation product, HNE, under basal conditions caused a significant reduction in Star mRNA levels in MLTC-1 and Y-1 cells, ranging from 30 to 80% (Fig. 3) . Likewise, preexposure of cells to these three oxidants caused a variable, but significant, reduction in Bt 2 cAMP-stimulated Star mRNA levels (Fig. 3) . These results indicate that exposure of steroidogenic cells to different oxidants results in downregulation of StAR gene expression. 
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Oxidant activation of p38 MAPK negatively affects cAMP transcriptional regulation of Star
The results described above indicate that oxidant exposure of steroidogenic cells results in downregulation of Star mRNA levels. As the p38 MAPK pathway has been implicated in mediating oxidative-stress-induced inhibition of steroid hormone synthesis (Abidi et al. 2008a,b) , we investigated the role of p38 MAPK signaling in oxidant modulation of cAMP-mediated transcriptional regulation of STAR protein. MLTC-1 cells were transiently transfected with a construct containing the promoter region (K2862) of rat Star, a control reporter construct containing Renilla luciferase for normalization of transfection efficiency and with or without an expression plasmid encoding FLAG-p38 MAPKa, and, after 48 h, cells were exposed to vehicle (control), superoxide anion (O 2 % K ), X/XO, the generator of O 2 % K ), H 2 O 2 , or HNE (a lipid peroxidation product) for an additional 60 min. After extensive washing, cells were treated with G Bt 2 cAMP (2.5 mM) for 3 h, harvested and cell lysates analyzed for firefly and Renilla luciferase activities or subjected to western blotting analysis for the measurement of total and phosphorylated (activated) forms of p38 MAPKa. As shown in Fig. 4A , short-term exposure of transfected cells to optimal doses of superoxide anion, H 2 O 2 , or HNE resulted in p38 MAPKa activation, as indicated by an increased level of phosphorylation at residues Thr 180 and attenuates mRNA expression of Star/StarD1 both under basal conditions and in response to cAMP stimulation. Cultured Y-1 and MLTC-1 cells were exposed to G 0.1 mM xanthine and 10 mU/ml XO or G 50 mM hydrogen peroxide (H 2 O 2 ) for 1 h. At the end of incubation, the dishes were washed and subsequently incubated with or without Bt 2 cAMP (2.5 mM) for 5 h, followed by isolation of total RNA and the quantification of the Star/StarD1 mRNA levels by qRT-PCR. Each value represents meanGS.E.M. of four separate determinations. ***P!0.0001 basal (control) vs Bt 2 cAMP.
Phospho-p38α
Total p38α p38α-wt Evaluation of the effects of p38 MAPKa (wt) overexpression and the effects of X/XO generated O 2 % K , H 2 O 2 , and 4-HNE on basal and cAMP-stimulated rat Star promoter (luciferase) activity in MLTC-1 cells. MLTC-1 cells were transiently transfected with a rat p-1862 Star-Luc (firefly luciferase) construct (1 mg)CRenilla luciferase (Rluc, pRL-TK) (50 ng) and G native p38 MAPKa (wt) (1 mg) using Lipofectamine 2000. After 48 h, dishes were exposed to G xanthine (0.1 mM)/XO (10 mU/ml), G 50 mM H 2 O 2 , or G 50 mM 4-hydroxynonenol (4-HNE) for 1 h, washed, incubated with or without Bt 2 cAMP (2.5 mM) for 5 h, cells were lysed using cell lysis buffer (Promega Corporation) and subsequently assayed for both firefly and Renilla luciferase activities using a Promega Dual-Luciferase Reporter Kit (E1980). In some cases, cell lysates were subjected to SDS-PAGE followed by western blotting analysis and the quantification of the total and the phosphorylated p38 MAPKa bands. (Fig. 4B) . Likewise, cAMP-stimulated promoter activity was also decreased with the introduction of p38 MAPKa. However, no additional decreases in cAMP-stimulated promoter activity were noted following oxidant exposure of p38 MAPKatransfected cells (Fig. 4B) . These p38 MAPKa overexpression studies indicate that inhibitory actions of oxidants on Star promoter activity are mediated by p38 MAPKa.
Effects of overexpression of native (wt) and dn p38 MAPK isoforms on Star promoter activity
The above findings indicate that p38 MAPKa exerts a negative effect on both basal and cAMP-stimulated Star promoter activity. To establish p38 MAPK isoform specificity, we next examined the relative efficacy of native (wt) p38 MAPKa, p38 MAPKb, p38 MAPKg, and p38 MAPKd and their respective dn forms on Star promoter activity. MLTC-1 cells were transfected with STAR-reporter luciferase plasmid alone or together with plasmids encoding native or dn FLAG-p38 MAPK isoforms, and luciferase activities were quantified. As before, expression of wt p38 MAPKa-wt reduced the basal promoter activity by approximately 50%, whereas expression of dn p38 MAPKa-dn enhanced the basal promoter activity by about twofold (Fig. 5A) . Qualitatively similar results were obtained when Y-1 or HEK-293 cells were substituted for MLTC-1 or rat Star promoter (p-1862-rat StAR) reporter construct was replaced with a mouse Star promoter reporter construct (p960-mouse Star; Manna et al. (2002) ; data not shown). Results presented in Fig. 5B and C show that overexpression of p38 MAPKb-wt or p38 MAPKg-wt also significantly suppressed the transfected rat Star promoter reporter activity both under basal conditions and in response to cAMP stimulation. On the other hand, expression of p38 MAPKb-dn, similar to p38 MAPKa-dn, enhanced basal as well as cAMP-stimulated promoter activity, but the use of p38 MAPKg-dn showed no such stimulatory effect. In contrast, expression of p38 MAPKdwt showed no inhibitory effect on promoter activity when measured under basal conditions, but significantly decreased cAMP-stimulated promoter activity (Fig. 5D ). On the other hand, transient overexpression of p38 MAPKd-dn variably but significantly enhanced cAMPstimulated promoter activity (Fig. 5D ). These results led us to conclude that p38 MAPKa and to a lesser extent p38 MAPKb, p38 MAPKg, and p38 MAPKd function as negative regulators of Star gene transcription.
To further establish the inhibitory action of p38 MAPKa on Star promoter activity, p38 MAPK inhibitor experiments were carried out. To this end, MLTC-1 cells were either transfected with Star promoter alone or Star promoter plus p38 MAPKa-wt construct and then treated with selective inhibitors of p38 MAPK, SB203580 and SB202190 (Bain et al. 2007) . Luciferase measurement results indicated that SB203580 or SB202190 treatment resulted in a small increase in basal promoter activity in MLTC-1 cells transfected with Star promoter alone ( Table 2) Effects of overexpression of wt and dn p38 MAPKa, p38 MAPKb, p38 MAPKg, and p38 MAPKd constructs on Star promoter activity in MLTC-1 cells. The cells were transiently transfected with p-1862 Star-Luc (firefly luciferase) construct plus Renilla luciferase (Rluc, pRL-TK), and empty vector, p38 MAPKa-wt, p38 MAPKa-dn, p38 MAPKb-wt, p38 MAPKb-dn, p38 MAPKg-wt, p38 MAPKg-dn, p38 MAPKd-wt, or p38 MAPKd-dn. Fortyeight hours after transfection, the dishes were washed and subsequently incubated with or without Bt 2 cAMP (2.5 mM) for 5 h and cells lysed using cell lysis buffer (Promega Corporation) and subsequently assayed for both firefly and Renilla luciferase activities. (A) p38 MAPKa, (B) p38 MAPKb, MAPKa resulted in an efficient reduction in Star promoter activity under basal conditions. This reduction in basal promoter activity was completely restored following treatment of transfected cells with either SB203580 or SB202190 (Table 2) . Qualitatively similar results were obtained when luciferase measurements were carried out using extracts from cAMP-treated cells (data not shown). The results presented in Fig. 6 demonstrate that transient overexpression of p38 MAPKa-wt in MLTC-1 cells significantly decreased the endogenous mRNA levels of STAR protein both under basal conditions and in response to cAMP stimulation. In contrast, transient overexpression of a p38 MAPKa-dn significantly upregulated both basal as well as cAMP-stimulated Star mRNA levels. These results further confirmed that p38 MAPKa negatively regulates the gene transcription of STAR protein.
MKK3 and MKK6 contribute to the p38 MAPK-mediated suppression of Star promoter activity
Two closely related dual-specificity upstream protein kinases, MKK3 and MKK6, phosphorylate and activate p38 MAPK at the activation site Thr-Gly-Tyr (Han et al. 1996 , Enslen et al. 1998 , Wysk et al. 1999 , Coulthard et al. 2009 , Cuadrado & Nebreda 2010 , Remy et al. 2010 . We determined whether MKK3 and MKK6 play a role in p38 MAPK-mediated suppression of Star promoter activity. MLTC-1 cells (which express predominantly p38 MAPKa but also significant amount of p38 MAPKb, Fig. 2 ) were co-transfected with a rat Star firefly luciferase reporter construct as described earlier (rat p-1862 StAR-Luc) plus a reporter construct containing Renilla luciferase (Rluc, pRL-TK) with or without a plasmid encoding a ca form of MKK3/MMK6, FLAG-MKK3-ca (MKK3 (EE))/FLAG-MKK6-ca (MKK6 (EE)), or a dn MKK3/MKK6, FLAG-MKK3-dn (MKK (AA))/FLAG-MKK6-dn (MKK (AA)). After 48 h, the cells were treated with or without Bt 2 cAMP (2.5 mM) for 5 h, harvested, and cell extracts analyzed for dual luciferase activities. As shown in Fig. 7A , overexpression of MKK3-ca significantly reduced both basal and cAMPstimulated promoter activity. In contrast, transfections with an MKK3-dn construct upregulated both the basal as well as cAMP-stimulated reporter activity. Likewise, overexpression of MKK6-ca led to a significant inhibition of basal and cAMP-stimulated Star promoter activity (Fig. 7A) . Similar to the effect of the dn form of MKK3, overexpression of MKK6-dn also enhanced promoter activity both under basal conditions and in response to cAMP stimulation. These results imply that both MKK3 and MKK6 are equally effective and participate in p38 MAPK-mediated repression of Star promoter activity. Effects of transient overexpression of wt and dominant-negative p38 MAPKa on basal and cAMP-stimulated endogenous mRNA levels of Star in MLTC-1 cells. MLTC-1 cells were transiently transfected with empty vector, p38 MAPKa-wt, or p38 MAPKa-dn and, 48 h after transfection, the dishes were washed and subsequently incubated with or without Bt 2 cAMP (2.5 mM) for 5 h. Following incubation, the dishes were subjected to total RNA isolation and the RNA samples quantified for Star (StarD1) mRNA levels by qRT-PCR. Each value represents meanGS.E.M. of four separate determinations. *P!0.01 Bt 2 cAMP p38a-dn vs basal (control) Bt 2 cAMP;
Next we undertook the approach of enzyme-substrate fusion (Robinson et al. 1998 , Zheng et al. 1999 , Qi et al. 2007 to further examine the MKK-p38 MAPK regulation of Star promoter activity. This approach is based on the fact that p38 MAPK becomes ca when linked to its upstream activator such as MKK6 (Qi et al. 2007) . Herein, we used constructs in which p38 MAPKa-ca, p38 MAPKg-ca, p38a/AGF-dn, or p38g/AGF-dn (representative p38 MAPKs) were fused in-frame with the activator MKK6 (MKK6 activates all isoforms of p38 MAPK) through a decapeptide linker as reported previously by Qi et al. (2007) . MLTC-1 cells were transiently transfected with Star promoter with or without expression vector encoding HA-MKK6-p38 MAPKa-ca, HA-MKK6-p38 MAPKg-ca, HA-MKK6-p38a/AGF-dn, or HA-MKK6-p38g/AGF-dn, and after 48 h cell lysates were analyzed for firefly and Renilla luciferase activities. As a positive control, some dishes were also transfected with p38 MAPKa (wt) or p38 MAPKa-dn plasmid DNA. Results presented in Fig. 7B demonstrate that transfection of cells with either MKK6-p38 MAPKa-ca or MKK6-p38 MAPKg-ca suppressed the expression of Star promoter activity, whereas use of MKK6-p38 MAPKa/AGFdn or MKK6-p38 MAPKg/AGF-dn enhanced the promoter activity. As expected, transfection of cells with p38 MAPKawt or p38 MAPKa-dn decreased and increased the promoter activity respectively. Thus, p38 MAPKs, including p38 MAPKa and their upstream activators MKK3 and MKK6, work in concert to modulate Star promoter activity.
To more directly define the roles that MKK3 and MKK6 play in p38 negative regulation of the Star promoter activity mediated by MAPKs, we assessed the expression of Star promoter activity in MEFs with targeted disruption of Mkk3 (Map2k3), Mkk6 (Map2k6) or both Mkk3 and Mkk6 genes. MKK3/6 (wt), MKK3 K/K , MKK6 K/K , and MKK3/6 K/K (DKO) MEFs (Brancho et al. 2003) were transfected with a rat Star reporter construct (48 h), treated with or without Bt 2 cAMP (2.5 mM, 5 h), and, subsequently, cell lysates analyzed for luciferase activities. As shown in Fig. 7C , expression of Star promoter activity was substantially higher (both basal and cAMP stimulated) in single MKK3 K/K or MKK6 K/K MEFs as compared with wt MEFs that express both MKK3 and MKK6. Interestingly, use of MKK3/6 K/K DKO MEFs produced no additive effect, indicating that MKK3 and MKK6 play complementary roles and activate similar p38 MAPKs, such as p38 MAPKa that mediate negative regulation of Star promoter activity. 
Figure 7
Regulation of Star promoter activity in MITC-1 cells in response to transient overexpression of MKK3, MKK6, or MKK6-p38 MAPKa/g constructs and mouse embryonic fibroblasts (MEFs) lacking MKK3, MKK6, or both.
(A) MLTC-1 cells were cotransfected with p-1862 Star-Luc (firefly luciferase) construct (1 mg) plus Renilla luciferase (Rluc, pRL-TK) (50 ng), and empty vector, p38 MAPKa-wt, p38 MAPKa-dn, MKK3-ca, MKK3-dn, MKK6-ca, or MKK6-dn. At the end of 48 h, the dishes were treated with or without Bt 2 cAMP (2.5 mM) for an additional 5 h and subsequently cell lysates assayed for firefly and Renilla luciferase activities. (B) MLTC-1 cells were transiently transfected with empty vector, p38 MAPKa-wt, p38 MAPKa-dn, MKK6-p38 MAPKa-ca, MKK6-p38 MAPKa-dn, MKK6-p38 MAPKg-ca, or MKK6-p38 MAPKg-dn and, after 48 h, further treated with or without Bt 2 cAMP for 5 h. Cell lysates were assayed for firefly and Renilla luciferase activities as described above. (C) Wt (MKK3/6) MEFs and MEFs deficient in
were co-transfected with p-1862 Star-Luc (firefly luciferase) and Renilla luciferase (Rluc, pRL-TK) constructs for 48 h, stimulated with or without Bt 2 cAMP for an additional 5 h, followed by determination of firefly and Renilla luciferase activities.
(D) MKK3/6 and MKK3 K/K /MKK6 K/K DKO MEFs were co-transfected with p-1862 Star-Luc (firefly luciferase) and Renilla luciferase (Rluc, pRL-TK) constructs. In a third set MKK3 K/K /MKK6 K/K DKO MEFs were co-transfected with MKK3-caCMKK6-ca plus p-1862 Star-Luc (firefly luciferase) and Renilla luciferase (Rluc, pRL-TK) constructs for 48 h followed by treatment with G Bt 2 cAMP. Cell lysates were assayed for firefly and Renilla luciferase activities, as described earlier. 
Finally, the results presented in Fig. 7D demonstrate that simultaneous overexpression of MKK3-ca and MKK6-ca in MKK3/6 K/K DKO MEFs significantly decreased both basal and c-AMP-stimulated Star promoter luciferase activity as compared with cells transfected with the control DNA.
cAMP-stimulated Star mRNA and progesterone levels in relation to p38 MAPK The above studies provided strong evidence that p38 MAPKs, particularly p38 MAPKa, function as negative regulators of Star promoter activity. We next evaluated the inhibitory actions of p38 MAPKa on steady-state Star mRNA levels and its relevance to steroidogenesis. Expression of p38 MAPKa-wt significantly decreased both basal and cAMP-induced Star mRNA levels. In contrast, when MLTC-1 cells were transfected with p38 MAPKa-dn, basal and cAMP-stimulated levels were significantly increased compared with levels for the control cells and the cells transfected with p38 MAPKa-wt (data not shown).
We also measured progesterone synthesis and secretion in the culture medium from cells transfected with either p38 MAPKa-wt or p38 MAPKa-dn and subsequently stimulated without or with Bt 2 cAMP. As shown in Table 3 , progesterone accumulation in each case paralleled changes in Star mRNA expression. The nonstimulated MLTC-1 cells transiently expressing p38 MAPKa (wt) decreased progesterone production by approximately 75-80%, whereas expression of p38 MAPKa-dn increased medium progesterone levels by approximately twofold. Likewise, cAMP-stimulated progesterone secretion by p38 MAPKa-wt-expressing cells was reduced by approximately 50% when compared with that seen in control cells. On the other hand, expression of p38 MAPKa-dn resulted in approximately a twofold increase in cAMP-stimulated progesterone production as compared with control cells (Table 3) .
Effect of p38 MAPK on CREB-mediated regulation of Star promoter activity
Expression of Star is mainly regulated at the transcriptional level through a cAMP-protein kinase A (PKA)-dependent mechanism (Manna et al. 2009 ). Herein, we examined the effect of p38 MAPK on CREB-mediated regulation of Star promoter activity. As the CREBdependent transcriptional response is primarily dependent on CREB phosphorylation (Shaywitz & Greenberg 1999 , Johannessen et al. 2004 , Altarejos & Montminy 2011 , we initially examined the effects of p38 MAPKa-wt and p38 MAPKa-dn on the cAMP/PKA-stimulated phosphorylation (Ser 133 ) of CREB protein in MLTC-1 cells. The results presented in Fig. 8 demonstrate the effects of p38 MAPKa-wt and p38 MAPKa-dn constructs on the levels of the cAMP/PKA-stimulated phosphorylated form of CREB (p-CREB). Transfection of cells with p38 MAPKa-wt increased cAMP-stimulated phospho-CREB levels, and the use of p38 MAPKa-dn resulted in much greater stimulation of its phospho-levels. The results presented in Fig. 8 also demonstrate that phosphorylation of ATF-1, which is 65% identical to CREB in its primary amino acid sequence (Shaywitz & Greenberg 1999) , was also increased in response to the overexpression of p38 MAPKa-wt or p38 MAPKa-dn construct. The potential effect of p38 MAPKa on CREB was further studied in MLTC-1 cells using a CRE-reporter (luciferase) construct. The data presented in Fig. 9A show that transient transfection of MLTC-1 cells with CRE, CREB, and p38 MAPKa-wt resulted in a significant reduction in basal CRE-luciferase activity as compared with cells transfected with CRE alone or CRECCREB. In contrast, transient expression of CRE, CREB, and p38 MAPKa-dn in these cells resulted in an approximately 50% increase in basal CRE-luciferase activity compared with results obtained with CRE or CRECCREB construct. Results presented in Fig. 9B demonstrate that co-transfection of the cells with p38 MAPKa-wt decreased the Bt 2 cAMPinduced luciferase activity. Expression of p38 MAPKa-dn construct, however, showed no effect on CRE-luciferase activity in response to cAMP stimulation (Fig. 9B) . We also evaluated the effects of overexpression of p38 MAPKa-wt and p38 MAPKa-dn on AP1 (TRE) luciferase activity in MLTC-1 cells. As illustrated in Fig. 9C and D, transient expression of p38 MAPKa-wt or p38 MAPKa-dn, however, showed no effect on AP1 luciferase activity either under basal conditions or in response to TPA stimulation. These results led us to conclude that p38 MAPKa inhibits cAMPinduced Star promoter activity primarily by interfering with the PKA-mediated CREB phosphorylation and its functional expression.
Discussion
STAR protein plays a pivotal role in the tropic peptide hormone-regulated acute phase of steroidogenesis, mediating the rate-limiting translocation of cholesterol from the OMM to the IMM, where side-chain cleavage enzyme Effects of overexpression of p38 MAPKa-wt and p38 MAPKa-dn on the levels of total (t) and phospho-forms of CREB in response to treatment of cells with or without Bt 2 cAMP. Cells were transfected with either an empty vector, p38 MAPKa-wt, or p38 MAPKa-dn, and, after 48 h, treated with or without Bt 2 cAMP. The cell lysates were subjected to SDS-PAGE followed by western blotting analysis. The blots were developed using anti-CREB ( p38 MAPKa-mediated downregulation of CRE (A and B), but not AP1/TRE (C and D), reporter activity in MLTC-1 cells. MLTC-1 cells were transfected with Cre-Luc (firefly luciferase)CRenilla luciferase (Rluc, pRL-TK), with or without CREB, or CREBCp38 MAPKa-wt or p38 MAPKa-dn for 48 h. At the end of the incubation, washed dishes were further incubated with or without Bt 2 -cAMP followed by measurement of firefly and Renilla luciferase activities. Likewise, cells were transfected with AP1/TRE-luc (firefly luciferase)CRenilla luciferase (Rluc, pRL-TK), with or without p38 MAPKawt or p38 MAPKa-dn, and, after 48 h, dishes were further incubated with or without AP1/TRE activator TPA (10 nM) for 30 min. The cell lysates were then quantified for firefly and Renilla luciferase activities. Each value represents meanGS.E.M. of four separate determinations. **P!0.01 CRE C CREB p38a-dn vs CRE C CREB p38a-wt; (P450scc; Cyp11A) carries out the first committed step in steroidogenesis, i.e. conversion of cholesterol to pregnenolone, the precursor of all steroid hormones (Stocco & Clark 1996 , Stocco 2001 , Hu et al. 2010 , Miller & Bose 2011 . We and others previously reported that expression of STAR protein is downregulated in both the adrenal gland and testicular Leydig cells of aging rats, and, as a result, adequate amounts of cholesterol are not transported to mitochondria, leading to defective steroidogenesis during aging (Leers-Sucheta et al. 1999 , Luo et al. 2005 , Wang et al. 2005 , Sun et al. 2008 . These changes have been linked to excessive oxidative stress and increased ROS production , Cao et al. 2004 , Abidi et al. 2008a ,b, Zaidi et al. 2012 . The observed increased expression of the active (phospho) form of oxidant-sensitive p38 MAPKa during aging led to the suggestion that this kinase mediates the anti-steroidogenic actions of excessive oxidative stress during aging (Abidi et al. 2008a,b (Soccio et al. 2005) . Similar to our data, however, the mRNA levels of StarD3 and StarD5 were induced by cAMP stimulation; the levels of StarD2, which is a phosphatidylcholine transfer protein (PCTP/StarD2) and StarD6, whose expression is limited to germ cells of testis (Soccio et al. 2002 , Gomes et al. 2006 , Bose et al. 2008 , were not determined in this model Leydig cell line (Soccio et al. 2005) . Interestingly, it has been shown that StarD6 exhibits similar activity to that of Star/StarD1 in inducing steroidogenesis in a cell-free mitochondrial system (Bose et al. 2008) . Our qRT-PCR measurements also indicated that p38 MAPKa is the predominant endogenous isoform in both cell lines, although significant expression of p38 MAPKb was also noted in MLTC-1 cells. In contrast, only low levels of p38 MAPKg and p38 MAPKd were detected in both cell types. These results are in agreement with an earlier report from this laboratory (Abidi et al. 2008b) , but are at variance with another report showing that p38 MAPKd is expressed at very high levels in human steroidogenic tissues (Wang et al. 1997 In accordance with a previous observation that ROSmediated excessive oxidative stress inhibits steroidogenesis (Margolin et al. 1990 , Gatzuli et al. 1991 , Endo et al. 1993 , Stocco et al. 1993 , Kodaman et al. 1994 , Musicki et al. 1994 , Carlson et al. 1995 , Diemer et al. 2003 , Abidi et al. 2008b ), our data demonstrate that treatment of Y-1 and MLTC-1 cells with oxidants, superoxide anion (O 2 % K ), H 2 O 2 , or a lipid peroxidation product, 4-HNE results in a significant reduction in the levels of Star mRNA both under basal conditions and in response to cAMP stimulation. In addition, we provide evidence that exposure of MLTC-1 cells transiently overexpressing p38 MAPKa to the above mentioned three oxidants resulted in increased phosphorylation (activation) of p38 MAPKa, along with decreased Star promoter activity. The specificity studies demonstrated that p38 MAPKa, p38 MAPKb, and p38 MAPKg were highly effective at suppressing Star promoter activity both under basal conditions and in response to cAMP stimulation, although p38 MAPKa was relatively more effective than p38 MAPKb or p38 MAPKg. In contrast, expression of dn forms of p38 MAPKa, p38 MAPKb, or p38 MAPKg increased the expression of basal as well as cAMP-stimulated promoter activity. Likewise p38 MAPKa/b inhibitors, SB203580 or SB202190, prevented p38 MAPKa-mediated suppression of promoter activity, further confirming that p38 MAPK functions as a negative regulator of Star gene transcription. Although overexpression of p38 MAPKd-wt construct exhibited no significant effect on basal Star promoter activity, transient overexpression of p38 MAPKd-dn, however, significantly increased the cAMP-stimulated promoter activity over the values seen with the use of p38 MAPKd-wt construct.
Finally, use of various constructs of upstream activators of p38 MAPKs, MKK3 and MKK6 (Derijard et al. 1995 , Raingeaud et al. 1995 , Han et al. 1996 , MKK6-p38-MAPKa, and MKK6-p38-MAPKg fusion constructs (Robinson et al. 1998 , Zheng et al. 1999 , Qi et al. 2007 and MEFs with targeted disruption of Mkk3, Mkk6, or both Mkk3 and Mkk6 genes (Brancho et al. 2003 , Kang et al. 2006 further established that p38 MAPKs, particularly oxidant-sensitive p38 MAPKa, are involved in the negative regulation of Star gene transcription.
Extensive evidence now indicates that the expression of Star is mainly regulated at the transcriptional level through a cAMP-PKA-dependent mechanism (Manna et al. 2009 ). Transcriptional activation of target genes by the cAMP-PKA signaling pathway is mainly achieved via cAMP-responsive element (CRE)-binding protein (CREB) transcription factor. cAMP-activated PKA catalyzes the phosphorylation of CREB at serine residue 133 (Altarejos & Montminy 2011) . Phosphorylation of CREB at Ser 133 is required for CREB-induced gene transcription and promotes recruitment of the transcriptional co-activator CREB-binding protein (CBP) and its paralogue p300 (Mayr & Montminy 2001) . Although Star promoter lacks a consensus CRE (TGACGTCA), three CRE-like sites, CRE1, CRE2, and CRE3, have been characterized in the proximal region of the Star promoter (Manna et al. 2002) , of which the CRE2 site overlaps with an AP1/TRE (5-TGA G / C CTCA-3)-binding site (Manna & Stocco 2007 ) that can bind both CRE (CREB and its family member CRE modulator (CREM), and ATF1 and also ATF2) and AP1/TRE (Fos/Jun)-binding proteins (Shaywitz & Greenberg 1999 , Shaulian & Karin 2002 ). Our findings demonstrate that transient overexpression of p38 MAPKa-wt increased phospho-CREB (p-Ser 133 ) levels, and the use of p38 MAPKa-dn resulted in a greater increase in phospho-CREB (p-Ser 133 ) levels. Interestingly, neither p38 MAPKa-wt nor p38 MAPKa-dn increased the phosphorylation status of ATF-1, which is 65% identical to CREB in its primary amino acid sequence (Shaywitz & Greenberg 1999) . At present, we do not know the precise mechanism(s) by which p38 MAPKa and p38 MAPKa-dn upregulate the cAMP-PKAmediated Ser 133 phosphorylation of CREB. As CREB is also a substrate for the p38 MAPK-regulated MSK kinase (Hauge & Frödin 2006) , it is possible that both PKA and MSK simultaneously but variably catalyze CREB phosphorylation and in this process lead to increased CREB phosphorylation. The data obtained with the dn form of the p38 MAPKa raised another possibility that other kinases (e.g. PKC, calmodulin kinases, and glycogen synthase kinase; Impey & Goodman 2001 , Johannessen et al. 2004 , Johannessen & Moens 2007 ) that also phosphorylate CREB may cooperate with p38 MAPKa/MSK and interfere with the ability of PKA to catalyze Ser 133 phosphorylation. These various possibilities are likely to decrease CREB activity and, consequently, Star gene transcription and its promoter activity. The potential effect of p38 MAPKa on CREB function was studied in MLTC-1 cells using a CRE-reporter (luciferase) approach. Various measurements led to the conclusion that p38 MAPKa, by interfering with PKAmediated Ser 133 phosphorylation of CREB, inhibits its function. On the other hand, both p38 MAPKa-wt and p38 MAPKa-dn proteins showed no significant effect on AP1 reporter activity. We used AP1 (TRE) as a control, because the CRE and AP1 (TRE) consensus sequences differ by only one nucleotide (CRE, TGACGTCA and AP1/TRE, TGACTCA) (Hai & Curran 1991 , Shaulian & Karin 2002 and both recognition sequences can bind ATF/CREB and the Fos/Jun family of proteins, albeit with a variable affinity (Hai & Curran 1991) . In summary, our data indicate that oxidant/ROS exposure of steroidogenic cells leads to simultaneous inhibition and activation of Star mRNA and phospho-p38 MAPK protein levels respectively. In addition, results regarding Star promoter activity reported in this study indicate that p38 MAPKa and to some extent p38 MAPKb and p38 MAPKg inhibit Star gene transcription and that upstream kinases, MKK3 and MKK6, play a significant role in this process. Finally, our data provide evidence that p38 MAPKa negatively regulates Star gene transcription by potentially interfering with cAMP-PKA-mediated phosphorylation and the functional expression of the CREB transcription factor.
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